Related Experiment Videos
A systematic review on the dual roles of microRNAs in ischemic stroke: mechanisms and effects
Nur Iffah Ishak1,2, Rosfaiizah Siran1,3, Wan Nor I'zzah Wan Mohamad Zain4
1Multidisciplinary Initiative in Neuroscience Discovery and Science (MINDS), Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor, Malaysia.
Background:
MicroRNAs (miRNAs) regulate key pathways in ischemic stroke with both protective and detrimental effects. Understanding these dual roles is important to developing novel therapeutic strategies for cerebral ischemia. This systematic review highlights key miRNAs under investigation, the dysregulation of miRNA expression, and the overall mechanism of miRNA function after ischemic stroke.
Methods:
A total of 20 preclinical in vivo studies from multiple databases (PubMed, Scopus, and Web of Science (WoS)) that modulate miRNA expression post-stroke, published within the last 5 years, were analyzed. To confirm its effectiveness, studies must include miRNA expression level, neurological function test, and infarction volume. Due to the heterogeneity of these studies, as evaluated by the SYRCLE risk of bias tool, a descriptive synthesis was employed to summarize the findings. This review was registered with PROSPERO (CRD42024552558).
Results:
During the onset of ischemia, there is a sudden upregulation of detrimental miRNAs, accompanied by downregulation of beneficial neuroprotective miRNAs. Beneficial miRNAs inhibited apoptosis, suppressed inflammation, reduced oxidative damage, protected the blood-brain barrier (BBB), promoted angiogenesis, and stimulated neurogenesis. Detrimental miRNAs inhibited critical neuroprotective signaling pathways, suppressed cellular defense mechanisms, promoted Reactive oxygen species (ROS) production, and accelerated ischemic injury. Some miRNAs play dual roles, promoting both apoptosis and neurogenesis.
Discussion:
MiRNA modulation demonstrated greater therapeutic potential when used in rationally designed combination therapies, such as two beneficial miRNAs (e.g., miR-210 + miR-126) or a combination of miRNA with other agents (e.g., miR-199a-5p inhibitor + AKT activator IGF-1). Despite the enormous potential of miRNA modulation therapy and numerous preclinical data, translating it from bench to bedside remains a challenge.
Conclusion:
MiRNAs play dual roles in ischemic stroke, mediating both injury and repair. Their pleiotropic actions position them as promising multi-targeted candidates for stroke therapy, provided translational barriers can be overcome.
Insights
MicroRNAs (miRNAs) have dual roles in ischemic stroke, causing both damage and repair. Combination therapies show promise for stroke treatment, but clinical translation remains a challenge.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators in ischemic stroke, exhibiting both protective and detrimental effects.
- Understanding the dual roles of miRNAs is crucial for developing novel therapeutic strategies for cerebral ischemia.
- This review examines miRNA expression, function, and dysregulation following ischemic stroke.
Purpose of the Study:
- To systematically review preclinical studies on miRNA modulation in ischemic stroke.
- To highlight key miRNAs, their dysregulated expression, and functional mechanisms post-stroke.
- To assess the therapeutic potential of miRNA modulation for cerebral ischemia.
Main Methods:
- Systematic review of 20 preclinical *in vivo* studies published within the last 5 years.
- Studies were sourced from PubMed, Scopus, and Web of Science (WoS).
- Inclusion criteria required miRNA expression levels, neurological function tests, and infarction volume data; descriptive synthesis was used due to study heterogeneity.
Main Results:
- Ischemic stroke onset involves upregulation of detrimental miRNAs and downregulation of beneficial neuroprotective miRNAs.
- Beneficial miRNAs promote angiogenesis, neurogenesis, and protect the blood-brain barrier, while detrimental miRNAs exacerbate injury.
- Some miRNAs exhibit dual roles, influencing both apoptosis and neurogenesis.
Conclusions:
- MiRNA modulation offers therapeutic potential, especially in combination therapies (e.g., dual miRNA or miRNA with other agents).
- Despite promising preclinical data, significant translational barriers hinder the clinical application of miRNA-based stroke therapies.
- MiRNAs' pleiotropic actions make them attractive multi-targeted candidates for stroke treatment, pending successful translation.
Related Concept Videos
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
MicroRNAs